As of January 22, 2025, Nurix Therapeutics (NRIX) has a market cap of $1.39 billion USD. According to our data, Nurix Therapeutics is ranked No.4706 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.39 B |
4.46%
|
Dec 31, 2024 | $1.33 B |
82.56%
|
Dec 29, 2023 | $0.73 B |
-6.01%
|
Dec 30, 2022 | $0.78 B |
-62.07%
|
Dec 31, 2021 | $2.05 B |
-11.95%
|
Dec 31, 2020 | $2.33 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Arvinas
ARVN
|
$1.25 B |
0.000 M
|
USA
|
Milestone Pharmaceuticals
MIST
|
$0.11 B |
-0.000 M
|
Canada
|
Kezar Life Sciences
KZR
|
$46.70 M |
0.000 M
|
USA
|
C4 Therapeutics
CCCC
|
$0.26 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Vir Biotechnology
VIR
|
$1.45 B |
0.000 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
Market Cap | = | NRIX Stock Price | * | NRIX Shares Outstanding |
= | $19.68 | * | 70.84 M | |
= | $1.39 B |